NEW YORK (GenomeWeb News) - Genome Corp., a sequencing start-up based in Providence, RI, has received a $250,000 seed capital investment from the Slater Technology Fund, the companies said today.
Genome Corp. was founded earlier this year to develop and commercialize a sequencing method it calls “massively parallel Sanger sequencing,” a single-molecule approach that is expected to "greatly accelerate the speed and significantly reduce the cost of genome sequencing," according to the firm.
Company co-founder and CSO, Kevin Ulmer, founded single-molecule sequencing company SEQ Ltd. in 1987. The firm was later purchased by Amersham Biosciences. Ulmer was also involved in forming Exact Sciences, and has served as a consultant at Helicos Biosciences.